BOGGIO, Elena
 Distribuzione geografica
Continente #
NA - Nord America 2.708
EU - Europa 2.531
AS - Asia 1.581
SA - Sud America 202
Continente sconosciuto - Info sul continente non disponibili 105
AF - Africa 67
OC - Oceania 2
Totale 7.196
Nazione #
US - Stati Uniti d'America 2.601
RU - Federazione Russa 609
SG - Singapore 492
IE - Irlanda 416
IT - Italia 399
DE - Germania 378
CN - Cina 377
HK - Hong Kong 222
SE - Svezia 207
VN - Vietnam 193
BR - Brasile 153
UA - Ucraina 121
FR - Francia 103
IN - India 89
GB - Regno Unito 83
FI - Finlandia 78
CA - Canada 67
BD - Bangladesh 50
KR - Corea 39
PL - Polonia 26
ES - Italia 25
ID - Indonesia 24
BJ - Benin 23
IR - Iran 21
MX - Messico 20
ZA - Sudafrica 20
CZ - Repubblica Ceca 19
AR - Argentina 18
JP - Giappone 16
NL - Olanda 16
AT - Austria 13
IQ - Iraq 11
CO - Colombia 10
EC - Ecuador 8
TR - Turchia 8
GR - Grecia 7
LT - Lituania 7
BE - Belgio 6
KE - Kenya 5
MD - Moldavia 5
VE - Venezuela 5
AE - Emirati Arabi Uniti 4
CL - Cile 4
EU - Europa 4
JM - Giamaica 4
JO - Giordania 4
LB - Libano 4
MA - Marocco 4
PH - Filippine 4
TN - Tunisia 4
BG - Bulgaria 3
CR - Costa Rica 3
DZ - Algeria 3
RO - Romania 3
BB - Barbados 2
EE - Estonia 2
EG - Egitto 2
ET - Etiopia 2
GE - Georgia 2
IL - Israele 2
KW - Kuwait 2
KZ - Kazakistan 2
MY - Malesia 2
NI - Nicaragua 2
NP - Nepal 2
PE - Perù 2
PY - Paraguay 2
SA - Arabia Saudita 2
UZ - Uzbekistan 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AL - Albania 1
AU - Australia 1
AZ - Azerbaigian 1
BM - Bermuda 1
BS - Bahamas 1
CG - Congo 1
DK - Danimarca 1
DM - Dominica 1
DO - Repubblica Dominicana 1
GP - Guadalupe 1
GT - Guatemala 1
LK - Sri Lanka 1
ML - Mali 1
NG - Nigeria 1
NO - Norvegia 1
NZ - Nuova Zelanda 1
PA - Panama 1
PK - Pakistan 1
QA - Qatar 1
RS - Serbia 1
SK - Slovacchia (Repubblica Slovacca) 1
SN - Senegal 1
SV - El Salvador 1
SY - Repubblica araba siriana 1
TH - Thailandia 1
TT - Trinidad e Tobago 1
TW - Taiwan 1
Totale 7.096
Città #
Dublin 411
San Jose 371
Hong Kong 220
Singapore 207
Jacksonville 203
Ashburn 183
Council Bluffs 130
Dearborn 109
Beijing 99
Chandler 97
Los Angeles 86
Moscow 79
Columbus 68
Dallas 68
Wilmington 63
Grafing 61
Munich 61
Piemonte 60
Lauterbourg 55
Ho Chi Minh City 54
Novara 54
Phoenix 45
Lawrence 44
New York 44
Princeton 44
Hanoi 42
Buffalo 39
Santa Clara 38
Seoul 37
Milan 35
Turin 34
San Mateo 31
São Paulo 31
Helsinki 27
Toronto 26
Düsseldorf 25
Vercelli 25
Cotonou 23
Orem 23
Bremen 20
Warsaw 20
Falkenstein 19
Poplar 19
Chicago 18
Frankfurt am Main 18
London 18
The Dalles 17
Ann Arbor 16
Brno 16
Brooklyn 15
Denver 15
Montreal 15
Amsterdam 14
Johannesburg 14
Monmouth Junction 14
Andover 13
Redondo Beach 13
Tokyo 13
Atlanta 12
Kunming 12
Boston 11
Chennai 11
Houston 11
Jakarta 11
Rome 11
Boardman 10
Guangzhou 10
Hefei 10
Mülheim 10
St Louis 10
Manchester 9
Norwalk 9
Nuremberg 9
San Giuliano Milanese 9
Tianjin 9
Zanjan 9
Dong Ket 8
Mexico City 8
Nanjing 8
Querétaro 8
Vienna 8
Baghdad 7
Belo Horizonte 7
Can Tho 7
Hillsboro 7
Jinan 7
Las Vegas 7
Stockholm 7
Turku 7
Ardabil 6
Assago 6
Cassano Magnago 6
Da Nang 6
Haiphong 6
Mumbai 6
Ottawa 6
Paris 6
Torino 6
Barnet 5
Berlin 5
Totale 4.002
Nome #
Inducible T-Cell Costimulator Mediates Lymphocyte/Macrophage Interactions During Liver Repair 180
Immunotherapy of experimental melanoma with ICOS-Fc loaded in biocompatible and biodegradable nanoparticles 179
Differential induction of IL-17, IL-10, and IL-9 in human T helper cells by B7h and B7.1. 163
Anti-cytokine autoantibodies in autoimmune diseases 162
B7h Triggering Inhibits the Migration of Tumor Cell Lines 160
Osteopontin binds ICOSL promoting tumor metastasis 160
A double blind randomized experimental study on the use of IgM-enriched polyclonal immunoglobulins in an animal model of pneumonia developing shock 157
A mutation in caspase-9 decreases the expression of BAFFR and ICOS in patients with immunodeficiency and lymphoproliferation 154
Subcutaneous inverse vaccination with PLGA particles loaded with a MOG peptide and IL-10 decreases the severity of experimental autoimmune encephalomyelitis 152
Role of Anti-Osteopontin Antibodies in Multiple Sclerosis and Experimental Autoimmune Encephalomyelitis 150
ICOS-Ligand Triggering Impairs Osteoclast Differentiation and Function In Vitro and In Vivo 148
Enhanced cytotoxic effect of camptothecin nanosponges in anaplastic thyroid cancer cells in vitro and in vivo on orthotopic xenograft tumors 146
Decreased function of Fas and variations of the perforin gene in adult patients with primary immune thrombocytopenia 143
B7H triggering inhibits osteoclast function in vitro and in vivo 139
Inducible t-cell costimulator ligand plays a dual role in melanoma metastasis upon binding to osteopontin or inducible t-cell costimulator 139
IL-17 protects T cells from apoptosis and contributes to development of ALPS-like phenotypes 137
Cerebrospinal fluid levels of tissue inhibitor of metalloproteinase 1 are increased in subjects with mild cognitive impairment 132
Specific transcriptional programs differentiate ICOS from CD28 costimulatory signaling in human Naïve CD4+ T cells 131
Osteopontin Bridging Innate and Adaptive Immunity in Autoimmune Diseases 129
Extracellular proteasome-osteopontin circuit regulates cell migration with implications in multiple sclerosis 129
Cutting-Edge Delivery Systems and Adjuvants in Tolerogenic Vaccines: A Review 128
In Vitro and In Vivo Therapeutic Evaluation of Camptothecin-Encapsulated β-Cyclodextrin Nanosponges in Prostate Cancer 124
Genomic and functional evaluation of TNFSF14 in multiple sclerosis susceptibility 123
Thrombin Cleavage of Osteopontin Modulates Its Activities in Human Cells In Vitro and Mouse Experimental Autoimmune Encephalomyelitis In Vivo 122
Anti-rasburicase antibodies induce clinical refractoriness by inhibiting the enzyme catalytic activity 122
Development and characterization of solid lipid nanoparticles loaded with a highly active doxorubicin derivative 117
Role of the co-stimulatory molecule inducible T-cell co-stimulator ligand (ICOSL) in the progression of experimental metabolic dysfunction-associated steatohepatitis 116
The -346T polymorphism of the SH2D1A gene is a risk factor for development of autoimmunity/lymphoproliferation in males with defective Fas function 115
Vitamin D Supplementation modulates ICOS+ and ICOS- regulatory T cell in siblings of Children with Type 1 Diabetes 114
Platelets: 'multiple choice' effectors in the immune response and their implication in COVID-19 thromboinflammatory process 113
Platelets, Protean Cells with All-Around Functions and Multifaceted Pharmacological Applications 108
Eltrombopag second-line therapy in adult patients with primary immune thrombocytopenia in an attempt to achieve sustained remission off-treatment: results of a phase II, multicentre, prospective study 108
ICOS-Fc as innovative immunomodulatory approach to counteract inflammation and organ injury in sepsis 107
Use of Poly Lactic-co-glycolic Acid Nano and Micro Particles in the Delivery of Drugs Modulating Different Phases of Inflammation 105
Variations of the perforin gene in patients with multiple sclerosis 105
Osteopontin induces soluble urokinase-type plasminogen activator receptor production and release. 104
Solid lipid nanoparticles carrying temozolomide for melanoma treatment. Preliminary in vitro and in vivo studies 103
Differential Modulation of Human M1 and M2 Macrophage Activity by ICOS-Mediated ICOSL Triggering 101
The Gut-Brain-Immune Axis in Autism Spectrum Disorders: A State-of-Art Report 100
Electrospun Collagen Scaffold Bio-Functionalized with Recombinant ICOS-Fc: An Advanced Approach to Promote Bone Remodelling 98
ICOSL Stimulation by ICOS-Fc Accelerates Cutaneous Wound Healing In Vivo 98
Discovery of a septin-4 covalent binder with antimetastatic activity in a mouse model of melanoma 97
Nanoemulsions as delivery systems for poly-chemotherapy aiming at melanoma treatment 97
Mutation of FAS, XIAP, and UNC13D genes in a patient with a complex lymphoproliferative phenotype. 96
Optimization of an Injectable, Resorbable, Bioactive Cement Able to Release the Anti-Osteoclastogenic Biomolecule ICOS-Fc for the Treatment of Osteoporotic Vertebral Compression Fractures 95
Variations of the UNC13D gene in patients with autoimmune lymphoproliferative syndrome. 95
Sr-Containing Mesoporous Bioactive Glasses Bio-Functionalized with Recombinant ICOS-Fc: An In Vitro Study 94
Triggering of B7h by the ICOS modulates maturation and migration of monocyte-derived dendritic cells. 93
Role of the C-terminal fragment of osteopontin in multiple sclerosis 92
Inducible T-cell co-stimulator (ICOS) and ICOS ligand are novel players in the multiple-myeloma microenvironment 90
Genes and Microbiota Interaction in Monogenic Autoimmune Disorders 89
Improvement in the anti-tumor efficacy of doxorubicin nanosponges in in vitro and in mice bearing breast tumor models 88
Parenteral Nanoemulsions Loaded with Combined Immuno- and Chemo-Therapy for Melanoma Treatment 86
Paclitaxel-loaded nanosponges inhibit growth and angiogenesis in melanoma cell models 86
A Computational Model for the Release of Bioactive Molecules by the Hydrolytic Degradation of a Functionalized Polyester-Based Scaffold 86
Immunogenetic Characterization of Primary Immune Thrombocytopenia (ITP) in Adults: Preliminary Results of the Unit Study 84
Serum levels of osteopontin are increased in SIRS and sepsis 83
Exploiting Nanomedicine for Cancer Polychemotherapy: Recent Advances and Clinical Applications 80
Role of tissue inhibitor of metalloproteinases-1 in the development of autoimmune lymphoproliferation 76
The role of osteopontin/anti-osteopontin antibodies in CIDP 73
Tuning of the immune response using peptides loaded in biocompatible and biodegradable nanoparticles 72
null 62
The Association of Axonal Damage Biomarkers and Osteopontin at Diagnosis Could Be Useful in Newly Diagnosed MS Patients 61
Totale 7.196
Categoria #
all - tutte 33.910
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 33.910


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022392 0 0 28 32 19 15 82 14 29 37 42 94
2022/2023919 58 45 71 11 64 72 30 54 436 14 41 23
2023/2024392 31 26 35 11 51 12 98 13 0 7 39 69
2024/2025834 30 13 39 19 30 70 83 87 190 63 32 178
2025/20263.191 152 129 214 449 335 219 488 477 210 253 213 52
2026/2027403 82 246 75 0 0 0 0 0 0 0 0 0
Totale 7.196